retatrutide clinical trial weight loss results ⭐️topline from TRIUMPH-1, a Phase 3 evaluating #retatrutide, an investigational GIP / GLP-1 / glucagon triple hormone receptor agonist, in adults with obesity or “overweight” VisualAbstract: Retatrutide reduces body weight

Months 2 through 3: dose escalation effects Each dose increase may bring a mild recurrence of initial side effects, typically lasting three to five days

While higher doses of semaglutide generally provide greater appetite suppression, even the maximum dose (2.4mg for Wegovy) won't completely eliminate hunger

Marzook, A., Tomas, A

This type of product may be less aligned with your needs if you require clinically validated weight management outcomes comparable to prescription medications, prefer full-disclosure CFU counts per individual strain, or expect rapid changes within the first week of use

Weight loss on these medications can include lean mass loss alongside fat loss

I was already protein-focused and understood intellectually how to feed myself properly